Lunenfeld Tanenbaum Research Institute, Sinai Health, Toronto, ON M5G 1X5, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada.
Int J Environ Res Public Health. 2021 Nov 22;18(22):12234. doi: 10.3390/ijerph182212234.
During the COVID-19 pandemic, outpatient psychotherapy transitioned to telemedicine. This study aimed to examine barriers and facilitators to resuming in-person psychotherapy with perinatal patients as the pandemic abates. We conducted focus group and individual interviews with a sample of perinatal participants ( = 23), psychotherapy providers ( = 28), and stakeholders ( = 18) from Canada and the U.S. involved in the SUMMIT trial, which is aimed at improving access to mental healthcare for perinatal patients with depression and anxiety. Content analysis was used to examine perceived barriers and facilitators. Reported barriers included concerns about virus exposure in a hospital setting (77.8% stakeholders, 73.9% perinatal participants, 71.4% providers) or on public transportation (50.0% stakeholders, 26.1% perinatal participants, 25.0% providers), wearing a mask during sessions (50.0% stakeholders, 25.0% providers, 13.0% participants), lack of childcare (66.7% stakeholders, 46.4% providers, 43.5% perinatal participants), general transportation barriers (50.0% stakeholders, 47.8% perinatal participants, 25.0% providers), and the burden of planning and making time for in-person sessions (35.7% providers, 34.8% perinatal participants, 27.8% stakeholders). Reported facilitators included implementing and communicating safety protocols (72.2% stakeholders, 47.8% perinatal participants, 39.3% providers), conducting sessions at alternative or larger locations (44.4% stakeholders, 32.1% providers, 17.4% perinatal participants), providing incentives (34.8% perinatal participants, 21.4% providers, 11.1% stakeholders), and childcare and flexible scheduling options (31.1% perinatal participants, 16.7% stakeholders). This study identified a number of potential barriers and illustrated that COVID-19 has fostered and amplified barriers. Future interventions to facilitate resuming in-person sessions should focus on patient-centered strategies based on empathy regarding ongoing risk-aversion among perinatal patients despite existing safety protocols, and holistic thinking to make access to in-person psychotherapy easier and more accessible for perinatal patients.
在 COVID-19 大流行期间,门诊心理治疗转为远程医疗。本研究旨在探讨随着大流行的缓解,重新开始为围产期患者提供面对面心理治疗的障碍和促进因素。我们对来自加拿大和美国的 SUMMIT 试验(旨在改善患有抑郁和焦虑的围产期患者获得精神保健的机会)的围产期参与者(n=23)、心理治疗提供者(n=28)和利益相关者(n=18)进行了焦点小组和个人访谈。内容分析用于检查感知到的障碍和促进因素。报告的障碍包括对在医院环境(77.8%的利益相关者、73.9%的围产期参与者、71.4%的提供者)或公共交通工具上(50.0%的利益相关者、26.1%的围产期参与者、25.0%的提供者)暴露于病毒的担忧、在治疗期间戴口罩(50.0%的利益相关者、25.0%的提供者、13.0%的参与者)、缺乏儿童保育(66.7%的利益相关者、46.4%的提供者、43.5%的围产期参与者)、一般交通障碍(50.0%的利益相关者、47.8%的围产期参与者、25.0%的提供者)以及为面对面治疗计划和安排时间的负担(35.7%的提供者、34.8%的围产期参与者、27.8%的利益相关者)。报告的促进因素包括实施和沟通安全协议(72.2%的利益相关者、47.8%的围产期参与者、39.3%的提供者)、在替代或更大的地点进行治疗(44.4%的利益相关者、32.1%的提供者、17.4%的围产期参与者)、提供激励措施(34.8%的围产期参与者、21.4%的提供者、11.1%的利益相关者)和儿童保育和灵活的日程安排选择(31.1%的围产期参与者、16.7%的利益相关者)。本研究确定了一些潜在的障碍,并说明 COVID-19 加剧了这些障碍。未来促进重新开始面对面治疗的干预措施应侧重于以同理心为基础的患者为中心的策略,这些策略考虑到了围产期患者对现有安全协议的持续风险规避,以及整体思维,使围产期患者更容易获得面对面的心理治疗。